News

  • TCT 2018
    San Diego, CA – September 21-25, 2018

    Semih Oktay, President and Founder of CardioMed Device Consultants, will be a panel participant at the FDA Townhall Meeting on Sunday, September 23, 2018. In addition,
    CardioMed’s consultants Dr. Wenda Carlyle, Mr. Peter Carlyle, Dr. Jasmine Patel, Ms. Candace Cederman, and Dr. Lisa Bellincampi will be in attendance. Please contact Jasmine Patel at jpatel@cardiomedllc.com to schedule a meeting with our team in San Diego. #TCT2018

  • EuroPCR 2018
    Palais des Congrès, Paris, France – May 22-25, 2018

    Semih Oktay, President and Founder of CardioMed Device Consultants, will be a panel
    participant at the PCR Innovators Day Paris on Monday, May 21, 8:00-18:00. He is also
    chairing a session on Changes in Medical Device Regulation in Europe – What Every
    Interventionists Should Know on Tuesday, May 22, 2018, 13:45-15:15. In addition,
    CardioMed’s consultants Dr. Wenda Carlyle, Mr. Peter Carlyle, Ms. Mona Advani,
    and Dr. Lisa Bellincampi will be in attendance. Please contact us
    at info@cardiomedllc.com to schedule a meeting with our team in Paris. #EuroPCR

  • Transcatheter Cardiovascular Therapies (TCT) Scientific Symposium
    Denver, CO – October 29, 2017 – November 2, 2017

    Semih Oktay, President and founder of CardioMed Device Consultants, will be a panel participant at the TCT FDA Town Hall Discussions. CardioMed’s Principal Consultants Ms. Mona Advani, Dr. Wenda Carlyle, Mr. Peter Carlyle and Ms. Candace Cederman will also be in attendance at the TCT symposium. CardioMed consultants will be available to meet with anyone interested in discussing potential projects. Please contact us at info@cardiomedllc.com to schedule any such meetings with our team during the TCT Symposium. Access TCT website at http://www.crf.org/tct

  • US-Japan MedTech Frontiers
    Tokyo, Japan – Nov. 6, 2017
    Senior Corporate Executive Symposium

    Semih Oktay, President and founder of CardioMed Device Consultants, will participate as a panel member in the Session entitled “Ecosystem of International Collaboration for Innovative Medical Device Development.”

    This half-day symposium is for senior executives of Japanese medical device companies. It is designed to promote C-level collaboration through presentations by US MedTech executives, discussions of “disruptive” medical device start-ups, collaboration models and the sharing of innovative business models and commercialization scenarios. https://www.usjmf.net/
  • US – Japan MedTech Frontiers
    Okinawa, Japan – Nov. 8, 2017
    Fourth Annual Innovation Forum

    Semih Oktay, President and founder of CardioMed Device Consultants, will give a presentation and serve as a panel member in a Session entitled “Growing Asia’s Medical Device Industry through Innovation and International Collaboration.”

    This event is hosted by the Economy, Trade and Industry Department of the Okinawa Prefecture government, the Okinawa General Bureau Cabinet Office, the Government of Japan, and the National University of the Ryukyus Hospital.  This full-day conference is open to all members of the medtech industry. https://www.usjmf.net/

  • International Conference for Innovations in Cardiovascular Systems (ICI)
    Tel Aviv, Israel – December 3 – 6, 2017

    Semih Oktay, President and founder of CardioMed Device Consultants, will be in attendance
    at the ICI. Dr. Oktay will speak at the Academy of Innovation Day as well as serve as a
    Faculty member of the ICI. Dr. Oktay will also be available to meet with any interested party
    to discuss potential projects. Please contact us at info@cardiomedllc.com to schedule a
    meeting with Dr. Oktay at the ICI. Access ICI website at: http://2017.icimeeting.com/

  • Webinar – In collaboration with our partner organization QMed Consulting
    September 22, 2017

    Elisa D. Harvey, DVM, PhD, Principal Consultant at the CardioMed
    Device Consultants, gave a webinar on the “Basics of Clinical Trials for Medical Devices at
    FDA. This webinar covered how FDA’s regulations, processes and recommendations for
    clinical studies of medical devices in the US (whether they are for 510(k)s or PMAs),
    including significant and nonsignificant risk studies, early feasibility, feasibility and pivotal
    studies, use of clinical data from outside the US, and pre-submissions. To view this webinar,
    please click on the following link. View this webinar​